<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92562">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097654</url>
  </required_header>
  <id_info>
    <org_study_id>CRF-C-12-05</org_study_id>
    <nct_id>NCT02097654</nct_id>
  </id_info>
  <brief_title>Clinical Trial of a New Software ENgine for the Assessment &amp; Optimization of Drug and Non-drug Therapy in Older peRsons</brief_title>
  <acronym>SENATOR</acronym>
  <official_title>Phase 1 of a Prospective, Multinational, Cluster‐Randomized, Open Label Parallel Arm Trial With Blinded Outcome Adjudication Quantifying the Efficacy of SENATOR in Reducing Adverse Drug Reactions in Older Hospitalized Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helix Health Ltd Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of East Anglia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>GABOmilliarium mbH &amp; Co KG Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ClinInfo SA France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NHS Grampian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto Nazionale di Ricovero e Cura per Anziani</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Landspitali University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Cork</source>
  <oversight_info>
    <authority>Ireland: Research Ethics Committee</authority>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <authority>Iceland: Ministry of Health and Social Security</authority>
    <authority>Spain: Ethics Committee</authority>
    <authority>Belgium: Ethics Committee</authority>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objective: To quantify the benefits of the SENATOR decision support software on the
      reduction of ADR rates in older hospitalized patients. Secondary Objectives: To evaluate the
      effect of SENATOR with regard to use of appropriate non‐pharmacological therapies in
      subjects with one core geriatric syndrome.

      Tertiary Objectives: to examine the association of SENATOR use with subject survival,
      morbidity and health related quality of life.

      Health Economic Objective: To examine the potential health economic consequences of using
      SENATOR.

      There are two study periods:

      Period I: Prospective multinational, multicentre observational study to estimate the
      baseline adjudicated medical and surgical ADR rates by clinical sub speciality in 6
      international sites.

      Period II: Prospective multinational, multicentre, cluster randomized, two parallel arm,
      open label, controlled trial, with blinded outcome ascertainment, of the efficacy of SENATOR
      software in reducing ADRs in older hospitalized subjects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Subjects adjudicated by the Potential Endpoint Committee as having at least one likely or certain, non‐trivial hospital acquired ADR</measure>
    <time_frame>Day 14 of hospital stay or discharge, which ever comes first</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean number of possible/probable/certain, non‐trivial hospital acquired ADRs per subject</measure>
    <time_frame>Day 14 of hospital stay or discharge, which ever comes first</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of pre‐specified ADRs per subject</measure>
    <time_frame>Day 14 of hospital stay or discharge, whichever comes first</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Appropriateness Index score at discharge</measure>
    <time_frame>Day 14 of hospital stay or discharge, which ever comes first</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of appropriate non‐drug therapy in subjects with one core geriatric syndrome i.e. Delirium</measure>
    <time_frame>Day 14 of hospital stay or discharge, whichever comes first</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Health related Quality of Life</measure>
    <time_frame>12 weeks post discharge</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>All‐cause mortality</measure>
    <time_frame>12 weeks post discharge</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Rehospitalisation</measure>
    <time_frame>12 weeks post discharge</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Composite healthcare utilization</measure>
    <time_frame>12 weeks post discharge</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Adverse Drug Reactions</condition>
  <arm_group>
    <arm_group_label>Hospitalized Elderly</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly (age 65 years and older) hospitalized with acute illness.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provision of informed consent by the patient or legal guardian/next‐of‐kin

          2. Age ≥ 65 years

          3. Arrival to hospital within previous 72 hours

          4. Admitted as a general medical or surgical on call patient

          5. Anticipated in‐hospital stay of &gt; 48 hours,

          6. ≥ 3 active (requiring current medication) chronic medical disorders

        Exclusion Criteria:

          1. Admitted under:

               -  Geriatric Medicine

               -  Clinical Pharmacology

               -  Palliative Medicine

               -  Clinical Oncology

               -  Hematology

          2. Intention of primary team at the time of subject admission to seek a Geriatric
             Medicine, Clinical Pharmacology or Palliative Medicine in‐patient consultation

          3. Life expectancy in the opinion of the admitting clinician of &lt; 3 months

          4. Admission directly to an intensive care unit,

          5. Admission with primary acute psychiatric illness (excluding delirium)

          6. Admission with non‐accidental overdose/self‐harm

          7. Anticipated immediate transfer to alternative non‐participating clinical
             service/hospital

          8. Clinical diagnosis of acute Liver failure

          9. estimated Glomerular Filtration Rate &lt;10 ml/min per 1.73 m2

         10. Solid organ transplant recipients

         11. Patients with malignancy receiving systemic chemotherapy

         12. Hospitalized for elective procedure

         13. Patient was more than 24 hours in the Emergency Department under the care of a
             different team to that which finally is in charge of them

         14. Patients who are actively participating in another clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joesph Eustace, MD FRCPI</last_name>
    <role>Study Director</role>
    <affiliation>University College Cork, Ireland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Cherubini, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS‐INRCA Ancona, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adalsteinn Gudmundsson, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Landspitali University Hospital, Iceland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfonso Cruz-Jentoft, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Ramōn y Cajal Madrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roy Soiza, MD FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>NHS Grampian, Aberdeen, Scotland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mirko Petrovic, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University Hospital, Ghent, Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Denis O'Mahony, MD FRCPI</last_name>
    <role>Study Chair</role>
    <affiliation>University College Cork, Ireland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denis O'Mahony, MD FRCPI</last_name>
    <phone>00353 21 4922396</phone>
    <email>denis.omahony@ucc.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary-Claire O'Regan, BEng</last_name>
    <phone>00353214901278</phone>
    <email>maryclaireoregan@ucc.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University College Cork</name>
      <address>
        <city>Cork</city>
        <state>Munster</state>
        <zip>2</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis O'Mahony, MD</last_name>
      <phone>00353214922317</phone>
      <email>denis.omahony@ucc.ie</email>
    </contact>
    <contact_backup>
      <last_name>Mary C O'Regan, BEng</last_name>
      <email>maryclaireoregan@ucc.ie</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <link>
    <url>http://www.senator-project.eu</url>
  </link>
  <link>
    <url>http://www.ucc.ie/en/crfc</url>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 28, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Cork</investigator_affiliation>
    <investigator_full_name>Denis O'Mahony</investigator_full_name>
    <investigator_title>Senior Lecturer, Department of Medicine</investigator_title>
  </responsible_party>
  <keyword>Hospital acquired</keyword>
  <keyword>Elderly</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Drug Toxicity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
